
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Liposomal glutathione is a phospholipid-encapsulated form of the tripeptide glutathione (L-γ-glutamyl-L-cysteinyl-glycine) designed to enhance oral bioavailability. The liposomal delivery system protects glutathione from degradation in the digestive tract, allowing for more efficient cellular uptake and antioxidant activity.

Reported Benefits (Provisional)
Origin & History

Glutathione is a tripeptide composed of glutamine, cysteine, and glycine. It is naturally produced in the liver and can be found in fruits, vegetables, and meats. Liposomal glutathione is enhanced for bioavailability by encapsulating it in liposomes, which are tiny lipid bubbles.
Research Narrative (Provisional)
Numerous studies, including randomized controlled trials, have demonstrated glutathione's role in reducing oxidative stress and supporting immune function. Meta-analyses confirm its efficacy in enhancing detoxification pathways.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Contains cysteine, glycine, and glutamine. - High antioxidant capacity. - Liposomal form increases absorption efficiency.
Reported Mechanism (Provisional)
Liposomal glutathione bypasses gastric degradation through phospholipid encapsulation, enabling direct cellular membrane fusion and intracellular delivery. Once inside cells, glutathione acts as a cofactor for glutathione peroxidase and glutathione S-transferase enzymes, neutralizing reactive oxygen species and conjugating toxins for elimination. The tripeptide also regenerates oxidized vitamins C and E while maintaining the reduced state of protein sulfhydryl groups.
Clinical Narrative (Provisional)
A randomized controlled trial of 54 adults showed that 500mg daily liposomal glutathione increased blood glutathione levels by 30-35% after 2 weeks, compared to minimal changes with oral reduced glutathione. Another study in 40 healthy adults demonstrated 7-fold higher peak plasma concentrations with liposomal formulations versus standard oral glutathione. However, most clinical research on glutathione's therapeutic effects has used intravenous administration rather than oral liposomal forms. More direct clinical trials are needed to confirm the therapeutic efficacy of liposomal delivery for specific health outcomes.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







